Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Performance of the American College of Obstetricians and Gynecologists' ovarian tumor referral guidelines with a multivariate index assay.

Sawaya GF, Jacoby V.

Obstet Gynecol. 2011 Nov;118(5):1178; author reply 1178-9. doi: 10.1097/AOG.0b013e3182356178. No abstract available.

PMID:
22015896
2.

Performance of the American College of Obstetricians and Gynecologists' ovarian tumor referral guidelines with a multivariate index assay.

Timmerman D, Van Calster B, Vergote I, Van Hoorde K, Van Gorp T, Valentin L, Bourne T.

Obstet Gynecol. 2011 Nov;118(5):1179-81; author reply 1181. doi: 10.1097/AOG.0b013e31823584db. No abstract available.

PMID:
22015898
3.

Performance of the American College of Obstetricians and Gynecologists' ovarian tumor referral guidelines with a multivariate index assay.

Ware Miller R, Smith A, DeSimone CP, Seamon L, Goodrich S, Podzielinski I, Sokoll L, van Nagell JR Jr, Zhang Z, Ueland FR.

Obstet Gynecol. 2011 Jun;117(6):1298-306. doi: 10.1097/AOG.0b013e31821b1d80.

PMID:
21555961
4.

Effectiveness of a multivariate index assay in the preoperative assessment of ovarian tumors.

Ueland FR, Desimone CP, Seamon LG, Miller RA, Goodrich S, Podzielinski I, Sokoll L, Smith A, van Nagell JR Jr, Zhang Z.

Obstet Gynecol. 2011 Jun;117(6):1289-97. doi: 10.1097/AOG.0b013e31821b5118.

PMID:
21606739
5.

How relevant are ACOG and SGO guidelines for referral of adnexal mass?

Dearking AC, Aletti GD, McGree ME, Weaver AL, Sommerfield MK, Cliby WA.

Obstet Gynecol. 2007 Oct;110(4):841-8.

PMID:
17906018
6.

Validation of referral guidelines for women with pelvic masses.

Im SS, Gordon AN, Buttin BM, Leath CA 3rd, Gostout BS, Shah C, Hatch KD, Wang J, Berman ML.

Obstet Gynecol. 2005 Jan;105(1):35-41.

PMID:
15625139
7.

Ovarian cancer screening. American College of Radiology. ACR Appropriateness Criteria.

Böhm-Vélez M, Mendelson E, Bree R, Finberg H, Fishman EK, Hricak H, Laing F, Sartoris D, Thurmond A, Goldstein S.

Radiology. 2000 Jun;215 Suppl:861-71. No abstract available.

PMID:
11037511
8.

Re: new guidelines to evaluate the response to treatment in solid tumors [ovarian cancer]. Gynecologic Cancer Intergroup.

Vergote I, Rustin GJ, Eisenhauer EA, Kristensen GB, Pujade-Lauraine E, Parmar MK, Friedlander M, Jakobsen A, Vermorken JB.

J Natl Cancer Inst. 2000 Sep 20;92(18):1534-5. No abstract available.

9.

The roles of second-look laparotomy and cancer antigen 125 in the management of ovarian carcinoma.

Selman AE, Copeland LJ.

Curr Oncol Rep. 1999 Sep;1(1):71-6. Review.

PMID:
11122801
10.

Diagnostic markers for ovarian cancer screening: not ready for routine clinical use.

Coates RJ, Kolor K, Stewart SL, Richardson LC.

Clin Cancer Res. 2008 Nov 15;14(22):7575-6; author reply 7577-9. doi: 10.1158/1078-0432.CCR-08-2296. No abstract available.

12.

CA-125 monitoring in ovarian cancer: patient survey responses to the results of the MRC/EORTC CA-125 Surveillance Trial.

Markman M, Petersen J, Belland A, Burg K.

Oncology. 2010;78(1):1-2. doi: 10.1159/000292352. No abstract available.

PMID:
20215782
13.

Doctor, should I get this new ovarian cancer test-OVA1?

Muller CY.

Obstet Gynecol. 2010 Aug;116(2 Pt 1):246-7. doi: 10.1097/AOG.0b013e3181e934ba. No abstract available.

PMID:
20664381
14.

Guidelines for referral of the patient with an adnexal mass.

Gostout BS, Brewer MA.

Clin Obstet Gynecol. 2006 Sep;49(3):448-58. Review.

PMID:
16885652
15.

Are there new ways to test my blood for ovarian cancer?

[No authors listed]

Health News. 2004 Nov;10(11):16. No abstract available.

PMID:
15655869
16.

Gynecologists' perspectives regarding ovarian cancer.

Fitch MI, Gray RE, Covens A, Thomas G, Franssen E, DePetrillo D, Rosen B.

Cancer Prev Control. 1999 Feb;3(1):68-76.

PMID:
10474755
17.

[Tumor marker CA 72-4 in ovarian cancer in comparison with CA 125 and D-dimer].

Schelling M, Jänicke F, Senekowitsch R, Lörken A.

Gynakol Rundsch. 1991;31 Suppl 2:286-9. German. No abstract available.

PMID:
1665138
18.

Circulating mucins as tumor markers in ovarian cancer (review).

Devine PL, McGuckin MA, Ward BG.

Anticancer Res. 1992 May-Jun;12(3):709-17. Review.

PMID:
1622128
19.

CA-125: a biomarker put to the test.

Schmidt C.

J Natl Cancer Inst. 2011 Sep 7;103(17):1290-1. doi: 10.1093/jnci/djr344. No abstract available.

20.
Items per page

Supplemental Content

Support Center